What is 22otters?
22otters specializes in mobile platforms designed to revolutionize healthcare by providing comprehensive support for patients undergoing various medical procedures. Their services include step-by-step guidance for procedure preparation, stoma care, discharge monitoring, and MRSA prevention, all enhanced with audio and visual displays for ease of use. The company aims to improve patient experience and outcomes through timely reminders and symptom checks, ensuring patients stay on track with their healthcare needs. Their intended clients include patients preparing for medical procedures and those seeking ongoing health management support. This focus on patient-centric digital health solutions positions 22otters as a key player in enhancing patient engagement and adherence.
How much funding has 22otters raised?
22otters has raised a total of $6.5M across 2 funding rounds:
Series A
$2.5M
Series B
$4M
Series A (2013): $2.5M with participation from Khosla Ventures Acquisition
Series B (2014): $4M led by Khosla Ventures Acquisition
Key Investors in 22otters
Khosla Ventures Acquisition
Khosla Ventures is a venture capital firm known for its investment in breakthrough technologies across various sectors including health and enterprise. Their strategic guidance and capital support are instrumental for companies aiming for significant market impact.
What's next for 22otters?
With a history of significant backing, including Series A and Series B rounds, 22otters is poised for further expansion. The recent major strategic investment signals a new phase of growth, likely focused on scaling operations, enhancing platform capabilities, and broadening market reach. This capital infusion will be instrumental in solidifying their position in the competitive digital health landscape and advancing their mission to improve patient outcomes through innovative mobile guidance.
See full 22otters company page
